Therapeutic Vaccines as Next Generation Biologics

The purpose of this project is to apply vaccine therapy as a next-generation biologics to the treatment of lifestyle-related diseases and intractable diseases, and to develop a basic technology for safer and more efficient therapeutic vaccines. This basic technology can be applied to the treatment of various diseases and has the potential to spread not only to developed countries but also to developing countries. To develop therapeutic vaccines for clinical application targeting the treatment of infectious diseases, lifestyle-related diseases, and intractable diseases and novel vaccine to deplete aging cells, AnGes Corporation, Daicel Corporation, and Funpep Corporation, together with the Department of Health Development and Medicine (Professor Nakagami), are collaborating in an industry-academic framework to develop a therapeutic vaccine, which will be originated in Japan. We will carry out translational research on therapeutic vaccines.

Principal Investigator